Nemaura Medical (NMRD +4.3%) has signed a letter of intent with privately held Healthimation, LLC related to a possible acquisition.
The Boston, MA-based company is commercializing an app-based diabetes prevention program aimed at maintaining patients’ muscle mass and enhancing metabolism to improve overall health while preventing weight gain.
Nemaura believes the app would be a “strong complement” to its proBEAT subscription service that it plans to offer in the U.S.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.